Charles York
Director Financiero/CFO en DAY ONE BIOPHARMACEUTICALS, INC. .
Fortuna: 3 M $ al 30/04/2024
Perfil
Charles N.
York is currently the Chief Operating & Financial Officer at DOT Therapeutics-2, Inc. and the Chief Operating & Financial Officer, Secretary at Day One Biopharmaceuticals, Inc. Previously, he worked as the Controller at Astrotech Corp.
from 2009 to 2012 and as the Chief Financial Officer, Secretary & VP at Spyre Therapeutics, Inc. from 2014 to 2021.
Mr. York obtained his undergraduate degree from the University of Connecticut in 1999 and his MBA from the McCombs School of Business in 2006.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 16/05/2024 | 224 868 ( 0.26% ) | 3 M $ | 30/04/2024 |
Cargos activos de Charles York
| Empresas | Cargo | Inicio |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Director Financiero/CFO | 01/02/2021 |
DOT Therapeutics-2, Inc.
 DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Director Financiero/CFO | 17/02/2021 |
Antiguos cargos conocidos de Charles York.
| Empresas | Cargo | Fin |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Director Financiero/CFO | 12/02/2021 |
| ASTROTECH CO. | Comptroller/Controller/Auditor | 01/08/2012 |
Formación de Charles York.
| University of Connecticut | Undergraduate Degree |
| McCombs School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| ASTROTECH CO. | Electronic Technology |
| DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Charles York
